Keywords: داربست بیرووروربل; Sirolimus; Paclitaxel; Drug-polymer interactions; Bioresorbable scaffold; Coating; Controlled release;
مقالات ISI داربست بیرووروربل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داربست بیرووروربل; Sirolimus; Bioresorbable scaffold; Biodegradable polymers; Extraction; Drug-eluting scaffold;
Keywords: داربست بیرووروربل; Sirolimus; Bioresorbable scaffold; Biodegradable polymers; Degradation; Release profile; Drug-eluting scaffold;
Keywords: داربست بیرووروربل; Bioresorbable scaffold; Bifurcation lesions; Optical coherence tomography;
Keywords: داربست بیرووروربل; Drug-eluting coronary stent; Bioresorbable scaffold; Corrosion resistance; Magnesium alloy; Biodegradable polymer; Controlled drug release;
Keywords: داربست بیرووروربل; bioresorbable scaffold; coronary artery; thrombosis;
Keywords: داربست بیرووروربل; BRS; bioresorbable scaffold; DAPT; dual antiplatelet therapy; MACE; major adverse cardiac event; ST; stent or scaffold thrombosis; TAT; triple antithrombotic therapy; TLF; target lesion failure; TLR; target lesion revascularization; TVF; target vessel fai
Keywords: داربست بیرووروربل; Neointimal proliferation; Bioresorbable scaffold; Peri-strut low intensity areas;
Keywords: داربست بیرووروربل; ABSORB; bioresorbable scaffold; vasomotion; IVUS; intravascular ultrasound; NTG; nitroglycerine; QCA; quantitative coronary angiography;
Keywords: داربست بیرووروربل; Bioresorbable scaffold; Drug-eluting stent; Hybrid; Percutaneous coronary intervention;
Keywords: داربست بیرووروربل; bioresorbable scaffold; optical coherence tomography; thrombosis; very late scaffold thrombosis;
Keywords: داربست بیرووروربل; Bioresorbable scaffold; Scaffold thrombosis;
Keywords: داربست بیرووروربل; bioresorbable scaffold; stent thrombosisACS, acute coronary syndromes; BVS, bioresorbable vascular scaffolds; DES, drug-eluting stents; LVEF, left ventricular ejection fraction; MLD, minimum lumen diameter; QCA, quantitative coronary angiography; RVD, ref
Keywords: داربست بیرووروربل; bioresorbable scaffold; coronary bifurcation; percutaneous coronary interventionBRS, bioresorbable scaffold; DES, drug-eluting stent(s); IVUS, intravascular ultrasound; KBI, kissing balloon inflation; MB, main branch; OCT, optical coherence tomography; PO
Keywords: داربست بیرووروربل; biodegradable polymer; bioresorbable scaffold; coronary intervention; intravascular ultrasound; optical coherence tomography; pathology; IQR; interquartile range; IVUS; intravascular ultrasound; OCT; optical coherence tomography; PLLA; poly-l-lactic-acid;
Keywords: داربست بیرووروربل; bioresorbable scaffold; first generation; periprocedural myocardial infarction; sirolimus-eluting stent; strut widthASSA, abluminal strut surface area; BRS, bioresorbable scaffold(s); CABG, coronary artery bypass graft; CI, confidence interval; CK-MB, cre
Keywords: داربست بیرووروربل; bioresorbable scaffold; coronary artery disease; optical coherence tomography; thrombosisBVS, bioresorbable vascular scaffold; CAD, coronary artery disease; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); IR, infrared; LCX, left circumflex ar
Keywords: داربست بیرووروربل; animals; bioresorbable scaffold; coronary artery imaging; pathologyBVS, bioresorbable vascular scaffold(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); IVUS, intravascular ultrasound; LA, lumen area; MLD, mean lumen diameter; RLA, refere
Keywords: داربست بیرووروربل; bioresorbable scaffold; endothelial shear stress; neointimal formation; optical coherence tomography3D, 3-dimensional; ESS, endothelial shear stress; IVUS, intravascular ultrasound; NT, neointimal thickness; OCT, optical coherence tomographic/tomography
Keywords: داربست بیرووروربل; bioresorbable scaffold; coronary artery diseaseBRS, bioresorbable scaffold(s); BVS, bioresorbable vascular scaffold; CE, Conformité Européenne; DES, drug-eluting stent(s); IVUS, intravascular ultrasound; MACE, major adverse cardiac event(s); OCT, optical
In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris - DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial
Keywords: داربست بیرووروربل; Coronary artery disease; Bioresorbable scaffold; Metal scaffold; DREAMS 2G; Magnesium scaffold; Sirolimus;
Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis
Keywords: داربست بیرووروربل; bioresorbable scaffold; thrombosis; BRS; bioresorbable stent(s); BVS; Bioresorbable Vascular Scaffold; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); MLD; minimum lumen diameter; QCA; quantitative coronary angiography; RVD; reference vessel
Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular Scaffolds
Keywords: داربست بیرووروربل; bioresorbable scaffold; computed tomography; diagnostic performance; AUC; area under the curve; BVS; bioresorbable vascular scaffold; CAD; coronary artery disease; CTA; computed tomography angiography; IVUS; intravascular ultrasound; MLA; minimal lumen ar
Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model
Keywords: داربست بیرووروربل; Endothelial shear stress; Bioresorbable scaffold; Computational fluid dynamic;
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold
Keywords: داربست بیرووروربل; bioresorbable; coronary; scaffold; sirolimus-eluting; BRS; bioresorbable scaffold; DES; drug-eluting stent(s); ITT; intention-to-treat; LLL; late lumen loss; MACE; major adverse cardiac events(s); MI; myocardial infarction; MLD; minimum lumen diameter; P
Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease
Keywords: داربست بیرووروربل; bioresorbable scaffold; coronary artery disease; percutaneous coronary intervention; BRS; bioresorbable scaffold(s); DAPT; dual-antiplatelet therapy; DES; drug-eluting metal stent(s); eBRS; everolimus-eluting bioresorbable scaffold(s); MACE; major adverse
Characteristics, Predictors, and Mechanisms of Thrombosis in Coronary Bioresorbable Scaffolds
Keywords: داربست بیرووروربل; bioresorbable scaffold; stent thrombosis; BRS; bioresorbable scaffolds; MLD; minimal lumen diameter; NSTEMI; non-ST-segment elevation myocardial infarction; QCA; quantitative coronary angiography; RVD; reference vessel diameter; ScT; scaffold thrombosis
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds
Keywords: داربست بیرووروربل; bioresorbable scaffold; prognosis; randomized trial; stent; BVS; bioresorbable vascular scaffold(s); DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); ID-TLR; ischemia-driven target lesion revascularization; MI; myocardial infarction; PCI; per
The State of the Absorb Bioresorbable Scaffold
Keywords: داربست بیرووروربل; bioresorbable scaffold; polymer poly-L-lactic acid; scaffold thrombosis; BRS; bioresorbable scaffold; CoCr-EES; cobalt-chromium everolimus-eluting stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); IVUS; intravascular ultrasound; OCT;
Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100
Keywords: داربست بیرووروربل; AS; Area stenosis; BRS; Bioresorbable scaffold; DES; Metallic drug-eluting stent; ISA; Incomplete strut apposition; IVUS; Intravascular ultrasound; MACE; Major adverse cardiac events; MLA; Minimal lumen area; MLD; Minimum lumen diameter; OCT; Optical cohe
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study)
Keywords: داربست بیرووروربل; Bioresorbable scaffold; Drug eluting stent; Overlap; Long lesions
Computational analysis of mechanical stress-strain interaction of a bioresorbable scaffold with blood vessel
Keywords: داربست بیرووروربل; Bioresorbable scaffold; Stent crimping; Stent deployment; Stresses; Eccentric plaque;
Are BVS suitable for ACS patients? Support from a large single center real live registry
Keywords: داربست بیرووروربل; ACS; acute coronary syndrome; BMS; bare metal stent; BVS; bioresorbable vascular scaffold; BRS; bioresorbable scaffold; CABG; coronary artery bypass grafting; CAD; coronary artery disease; CEC; clinical events committee; DES; drug-eluting stent; ITT; inte
Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions
Keywords: داربست بیرووروربل; bioresorbable scaffold; multimodality imagingFIM, first in man; ITT, intention to treat; IVUS, intravascular ultrasound; MACE, major adverse cardiac event(s); OCT, optical coherence tomography; PLLA, poly-l-lactic-acid; QCA, quantitative coronary angiogra
Simplifying the double kissing (DK) crush with the use of bioresorbable scaffolds
Keywords: داربست بیرووروربل; Bioresorbable scaffold; Double kissing crush; Bifurcation; Coronary aneurysm; Polymer-free stent;
Snowshoe Versus Ice Skate for Scaffolding of Disrupted Vessel Wallâ
Keywords: داربست بیرووروربل; bioresorbable scaffold; periprocedural MI; strut footprint;
Bioresorbable Scaffolds Versus Metallic Drug-Eluting Stents
Keywords: داربست بیرووروربل; bioresorbable scaffold; drug-eluting stent; percutaneous coronary interventions;
Impact of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population
Keywords: داربست بیرووروربل; BVS; bioresorbable vascular scaffold; DES; drug-eluting stent; IVUS; intravascular ultrasound; MACE; major adverse cardiac event; OCT; optical coherence tomography; PLLA; poly-L-lactic acid; SD; standard deviation; TLR; target lesion revascularization; TV
Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent
Keywords: داربست بیرووروربل; bioresorbable scaffold; cardiac biomarker; device overlap; periprocedural myocardial infarction; CB; cardiac biomarker; CI; confidence interval; CK; creatine kinase; CK-MB; creatine kinase-myocardial band; EES; everolimus-eluting stent(s); IVUS; intravasc
Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Keywords: داربست بیرووروربل; bioresorbable scaffold; major adverse cardiac event(s); maximal lumen diameterCI, confidence interval; Dmax, maximal lumen diameter; ID, ischemia-driven; MACE, major adverse cardiac event(s); MI, myocardial infarction; MLD, minimal lumen diameter; OCT, op
Shedding Light on Scaffold Vascular Responseâ
Keywords: داربست بیرووروربل; bioresorbable scaffold; edge vascular response; in-scaffold vascular response; optical coherence tomography;
Scaffold and Edge Vascular Response Following Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffold: A 3-Year Serial Optical Coherence Tomography Study
Keywords: داربست بیرووروربل; Absorb BVS; bioresorbable scaffold; edge vascular response; in-scaffold vascular response; optical coherence tomography; BMS; bare-metal stent(s); BRS; bioresorbable scaffold(s); BVS; bioresorbable vascular scaffold(s); CI; confidence interval; DES; drug-
1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis of the ABSORB and the SPIRIT Trials
Keywords: داربست بیرووروربل; bioresorbable scaffold; coronary artery disease; diabetes mellitus; drug-eluting stent; ARC; Academic Research Consortium; BMS; bare-metal stent(s); BVS; bioresorbable vascular scaffold; CAD; coronary artery disease; DES; drug-eluting stent(s); DoCE; devi
Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold: Optical Coherence Tomography Assessment in the ABSORB Cohort B Trial (
Keywords: داربست بیرووروربل; atherosclerosis; biodegradable polymer; bioresorbable scaffold; everolimus; stent; BVS; bioresorbable polymeric vascular scaffolds; Dmax; maximum diameter; IVUS; intravascular ultrasound; OCT; optical coherence tomography; QCA; quantitative coronary angio
Five-Year Clinical and Functional Multislice Computed Tomography Angiographic Results After Coronary Implantation of the Fully Resorbable Polymeric Everolimus-Eluting Scaffold in Patients With De Novo Coronary Artery Disease : The ABSORB Cohort A Trial
Keywords: داربست بیرووروربل; bioresorbable scaffold; everolimus; multislice computed tomography; noninvasive functional assessmentCT, computed tomography; FFR, fractional flow reserve; FFRCT, noninvasive fractional flow reserve according to multislice computed tomography; ID, ischemi
Avances en el tratamiento mediante intervención coronaria percutánea: el stent del futuro
Keywords: داربست بیرووروربل; EBA; estructura bioabsorbible; IM; infarto de miocardio; MACE; eventos adversos cardiovasculares mayores; PLT; pérdida luminal tardÃa; SLF; stent liberador de fármaco; SLS; stent liberador de sirolimus; SMSR; stent metálico sin recubrimiento; TS; trom
Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis : 12-Month Clinical and Imaging Outcomes
Keywords: داربست بیرووروربل; angiography; bioresorbable scaffold; coronary artery disease; intravascular ultrasound; optical coherence tomography2D, 2-dimensional; 3D, 3-dimensional; Ach, acetylcholine; CK, creatine kinase; CK-MB, creatine kinase-myocardial band; DC, dense calcium; I